Minic Z, O'Leary DS, Scislo TJ. NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism. Am J Physiol Heart Circ Physiol 309: H185-H197, 2015. First published April 24, 2015 doi:10.1152/ajpheart.00838.2014.-Adenosine is a powerful central neuromodulator acting via opposing A 1 (inhibitor) and A 2a (activator) receptors. However, in the nucleus of the solitary tract (NTS), both adenosine receptor subtypes attenuate cardiopulmonary chemoreflex (CCR) sympathoinhibition of renal, adrenal, and lumbar sympathetic nerve activity and attenuate reflex decreases in arterial pressure and heart rate. Adenosine A 1 receptors inhibit glutamatergic transmission in the CCR pathway, whereas adenosine A 2a receptors most likely facilitate release of an unknown inhibitory neurotransmitter, which, in turn, inhibits the CCR. We hypothesized that adenosine A 2a receptors inhibit the CCR via facilitation of GABA release in the NTS. In urethane-chloralose-anesthetized rats (n ϭ 51), we compared regional sympathetic responses evoked by stimulation of the CCR with right atrial injections of the 5-HT 3 receptor agonist phenylbiguanide (1-8 g/kg) before and after selective stimulation of NTS adenosine A 2a receptors [microinjections into the NTS of CGS-21680 (20 pmol/50 nl)] preceded by blockade of GABA A or GABAB receptors in the NTS [bicuculline (10 pmol/100 nl) or SCH-50911 (1 nmol/100 nl)]. Blockade of GABA A receptors virtually abolished adenosine A2a receptor-mediated inhibition of the CCR. GABAB receptors had much weaker but significant effects. These effects were similar for the different sympathetic outputs. We conclude that stimulation of NTS adenosine A 2a receptors inhibits CCR-evoked hemodynamic and regional sympathetic reflex responses via a GABA-ergic mechanism.
ADENOSINE modulates cardiovascular reflexes primarily integrated in the nucleus of the solitary tract (NTS) via inhibitory A 1 receptors and facilitatory A 2a receptors linked to G i and G s proteins, respectively (1, 10, 34, 42, 49, 54, 58, 64) . Activation of adenosine A 1 and A 2a receptors inhibits and facilitates neurotransmitter release and central neurons via pre-and postsynaptic mechanisms, respectively. Under physiological conditions, a natural source of adenosine in the NTS is ATP released from nerve terminals and glial cells and then catabolized by ectonucleotidases; this mechanism may be triggered by stress/hypothalamic defense responses (15, 59 -61, 77) . Under pathological conditions such as ischemia, hypoxia, and severe hemorrhage, intracellular ATP is catabolized to adenosine, and adenosine is globally released from hypoxic neurons and glial cells (31, 40, 55, 69, 73, 73, 74) . Therefore, adenosine acts spatially reaching both A 1 and A 2a receptors in the NTS neuronal network. However, this neuromodulator produces specific patterns of autonomic responses most likely due to the differential location of these two antagonistic receptors on NTS neurons/terminals, which participate in different reflexes and finally target different sympathetic outputs (45, 49, 50, 53, 54) . Selective activation of NTS A 1 and A 2a receptors usually but not always yields reciprocal results. For example, activation of A 2a receptors results in depressor responses accompanied with contrasting regional sympathetic responses: decreases in renal sympathethetic nerve activity (RSNA), increases in preganglionic adrenal sympathetic nerve activity (pre-ASNA), and no changes in lumbar sympathetic nerve activity (LSNA) (45, 50) . In contrast, selective activation of NTS adenosine A 1 receptors evokes mostly pressor responses accompanied with differential increases in regional sympathetic activity (pre-ASNA Ͼ RSNA Ն LSNA) (53) . Selective stimulation of NTS A 1 and A 2a receptors has also different effects on the integration of baroreflex control of regional sympathetic outputs: A 1 receptors inhibit glutamatergic transmission, which uniformly shifts the baroreflex stimulus response functions for RSNA, pre-ASNA, and LSNA toward higher mean arterial pressure (MAP) (48, 53) ; in contrast, A 2a receptors do not alter the baroreflex set point, although they decrease the baseline level of neural activity as well as the gain and range of the reflex for RSNA and increase all of these variables for pre-ASNA via nonbaroreflex mechanisms (21) .
These two antagonistic receptors may also act in concert to inhibit the cardiopulmonary chemoreflex (CCR) control of regional sympathetic outputs within the NTS but do so via very different mechanisms. The CCR (also known as the BezoldJarisch reflex) is triggered by polymodal mechano-and chemoreceptors and is mediated in rats by afferent vagal C-fibers (12, 37, 38, 44, (65) (66) (67) . This reflex evokes profound depressor, cardiac-slowing, and sympathoinhibitory responses, which can lead to fainting and have been occasionally attributed to sudden cardiac death in young athletes (9, 27, 44) . Inasmuch as activation of A 1 receptors inhibits neurotransmitter release, these receptors likely inhibit the CCR within the NTS by inhibiting glutamatergic transmission in the CCR pathway similarly as it occurs in the arterial baroreflex network (20, 48) . In contrast, facilitatory A 2a receptors may inhibit the CCR reflex pathway via release of an inhibitory neurotransmitter (32) . Our recent study showed that adenosine naturally released into the NTS during severe hemorrhage inhibits CCR control of regional sympathetic outputs similarly as do exogenously applied agonists of adenosine receptor subtypes (20, 31, 32) .
The most likely candidate for A 2a receptor-mediated inhibition of the CCR arc is GABA, as stimulation of central adenosine A 2a receptors does facilitate GABA release in dif-ferent neuronal networks, including respiratory reflexes integrated in the NTS (2, 13, 16, 17, 19, 28, 29, 39, 57, 72) . Negative GABAergic feedback operating at the level of the NTS in arterial baroreflex and chemoreflex pathways is well documented (22, 23, 26, 30, 62, 68, 70, 75, 76) . There is extensive evidence that both GABA A and GABA B receptors operate synergistically, inhibiting these reflexes at the level of the NTS (22, 62, 68, 75, 76) . Both GABA A and GABA B receptors are tonically active in the modulation of the baroreflex network at the level of the NTS (22, 62, 76) . It is unknown if GABAergic negative feedback also operates in the CCR pathway, although Zhang and Mifflin (76) speculated that GABA may be involved in the regulation of all cardiovascular reflexes integrated in the NTS. Therefore, since activation of A 2a receptors in the NTS inhibits the CCR and these receptors facilitate neurotransmitter release, we hypothesized that these receptors facilitate GABA release, which thereby inhibits the CCR control of regional sympathetic outputs. The present study was designed to answer the following questions: 1) Do NTS adenosine A 2a receptors inhibit the CCR control of regional sympathetic outputs via facilitation of GABAergic mechanisms in the NTS network? 2) Are both GABA A and GABA B receptors involved? and 3) Does GABA tonically inhibit the CCR pathway under normal conditions?
METHODS
All protocols and surgical procedures used in this study were reviewed and approved by the Institutional Animal Care and Use Committee and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals endorsed by the American Physiological Society.
Design. Experiments were performed using 51 male SpragueDawley rats weighing 373.5 Ϯ 6.9 g. In 27 rats, the contribution of GABAergic mechanisms to adenosine A 2a receptor-mediated inhibition of CCR responses of regional neural and hemodynamic variables was assessed; CCR stimulus response function curves obtained under control conditions were compared with curves obtained after bilateral microinjections into the NTS of an adenosine A 2a receptor agonist (CGS-21680; 20 pmol/50 nl) after pretreatment with vehicle control [microinjections of 100 nl artificial cerebrospinal fluid (ACF)] or blockade of NTS GABA A or GABAB receptors [microinjections of bicuculline (10 pmol/100 nl) or SCH-50911 (1 nmol/100 nl), respectively]. To assess potential tonic effects of NTS GABAergic mechanisms on the CCR control of regional neural and hemodynamic variables, in 24 rats, CCR function curves were compared before and after the GABA A or GABAB receptor blockade alone. CCR reactivity was also assessed ϳ1 h after the pharmacological manipulation in the NTS (recovery). The timeline of the protocol is shown in Fig. 1 .
Instrumentation and measurements. All procedures have been previously described in detail (20, 46, (51) (52) (53) . Briefly, male SpragueDawley rats (Charles River) were anesthetized with a mixture of ␣-chloralose (80 mg/kg) and urethane (500 mg/kg ip), tracheotomized, connected to a small animal respirator (SAR-830, CWE, Ardmore, PA), and artificially ventilated with a 40% O 2-60% N2 mixture. Arterial blood gases were tested occasionally (ABL500, OSM3, Radiometer), and ventilation was adjusted to maintain PO 2 Sinoaortic denervation was performed and tested similarly as in previous studies from our laboratory; special attention was given to preserve the vagus nerve (20, 46, 51, 53) .
Neural recording. In each experiment, simultaneous recordings from three (n ϭ 41) or two (n ϭ 10) sympathetic outputs were performed. Renal and adrenal nerves were exposed retroperitoneally from a flank incision, whereas the lumbar sympathetic trunk was exposed by a midabdominal incision. Neural recordings were accomplished as previously described (20, 46, (51) (52) (53) . Neural signals were initially amplified (ϫ2,000 -20,000) with bandwidth set at 100-1,000 Hz, digitized, rectified, and averaged in 1-s intervals. Background noise was determined after the animal was euthanized yet artificially ventilated to leave unaltered any potential movement artifacts. The resting level of nerve activity was normalized to 100% before each activation of the CCR.
The ratio between preganglionic and total nerve activity was initially tested with an intravenous bolus injection of the short-lasting (1-2 min) ganglionic blocker Arfonad [trimethaphan (2 mg/kg), Hoffmann-La Roche] and finally evaluated at the end of each experiment with hexamethonium (20 mg/kg iv). RSNA was virtually completely postganglionic, and 7.3 Ϯ 2.4% (n ϭ 48) of the activity persisted after the ganglionic blockade; LSNA was mostly postganglionic, and 34.9 Ϯ 4.3% (n ϭ 51) of preganglionic activity remained after the blockade. A total of 43 adrenal nerves were recorded: 28 adrenal nerves were predominantly pre-ASNA (Ͼ75% of activity remained after the ganglionic blockade), 7 adrenal nerves were predominantly postganglionic ASNA (post-ASNA; Ͻ50% of activity remained after the ganglionic blockade), and 8 adrenal nerves had intermediate composition (int-ASNA; 50%Ϫ75% of activity remained after the ganglionic blockade). Average levels of pre-ASNA, int-ASNA, and post-ASNA after ganglionic blockade were as follows: 90.2 Ϯ 2.2%, 62.4 Ϯ 3.0%, and 34.7 Ϯ 7.3%, respectively. Stimulation of the CCR similarly inhibits all three components of the adrenal nerve, although this inhibition is significantly different than the inhibition of RSNA and LSNA (RSNA Ͼ ASNA Ͼ LSNA) (20, 32) . Therefore, in the present study, all components of the adrenal nerve were combined for further analysis and referred to as ASNA (n ϭ 43). Arterial pressure and neural signals were digitized and recorded with a Hemodynamic and Neural Data Analyzer (Biotech Products, Greenwood, IN), averaged over 1-s intervals, and stored on a hard disk for subsequent analysis.
Microinjections into the NTS. Bilateral microinjections of the volume control [ACF (100 nl)] and GABA A or GABAB receptor blockade [bicuculline (10 pmol/100 nl) or SCH-50911 (1 nmol/100 nl), respectively] followed ϳ2-3 min later by the selective adenosine A2a receptor agonist CGS-21680 (20 pmol in 50 nl ACF) were made with multibarrel glass micropipettes into the medial region of the caudal NTS, as previously described (6, 20, 51, 53) . The doses and volumes of the agonist and antagonist were the same as used in our previous studies (20, 21, 48, 52, 53, 55) and similar to those used by others (22, 35, 62, 68) . Drugs were dissolved in ACF with pH adjusted to 7.2 since the selective adenosine A 2a receptor agonist CGS-21680 often precipitates at pH Ͼ 7.2. All microinjection sites were marked with DiI lypophilic dye (Molecular Probes) and verified histologically as previously described (6, 20, 51, 53) . Microinjection sites are shown in Fig. 2 using diagrams based on the atlas of the rat subpostremal NTS by Barraco et al. (4) .
CCR stimulus-response curves. Cardiopulmonary receptors were stimulated using bolus injections into the right atrium of increasing doses (1-8 g/kg) of the serotonin (5-HT) 3 receptor agonist PBG (20 g/1 ml solution in 0.9% NaCl, Sigma) in 2.5-min intervals between injections (20, 46, 47) . The total time to complete the stimulusresponse curve was ϳ8 min. Curves obtained under control conditions were compared with those obtained 30 min later, ϳ2.5 min after bilateral microinjections of pharmacological agents into the caudal NTS [either ACF (100 nl) or bicuculline (10 pmol/100 nl) or SCH- 
50911
(1 nmol/100 nl) followed by CGS-21680 (20 pmol/50 nl) or bicuculline (10 pmol/100 nl) or SCH-50911 (1 nmol/100 nl) alone] and again with curves obtained 60 min after the microinjections (recovery; Fig. 1 ). This approach allowed the assessment of CCR reactivity during the most effective action of the adenosine A 2a receptor activation, which occurs ϳ 5-15 min after the microinjection of the agonist (CGS-21680) (51, 52) .
Data analysis. The cardiopulmonary reflex stimulus-response curves constructed for MAP, heart rate (HR), RSNA, ASNA, and LSNA under control conditions were compared with those generated after bilateral stimulation of NTS adenosine A 2a receptors [CGS-21680 (20 pmol/50 nl)] preceded by either volume control [ACF (100 nl)] or GABA A [bicuculline (10 pmol/100 nl)] or GABAB [SCH-50911 (1 nmol/100 nl)] receptor blockade. CCR function curves were also compared before and after blockade of either GABA A or GABAB receptors alone. Additionally, control CCR stimulus-response curves were compared with those generated ϳ60 min after the microinjections (recovery). Maximal reflex responses in all measured variables were compared between the experimental conditions: ACF ϩ CGS-21680 versus bicuculline ϩ CGS-21680 or SCH-50911 ϩ CGS-21680 and bicuculline alone versus SCH-50911 alone. Effects exerted by activation of A 2a receptors preceded by volume control or GABAergic blockade on reflex responses were calculated according to the following equation: [(control response Ϫ response after the microinjection into the NTS)/control response] ϫ 100%; 100% inhibition reflects a completely abolished CCR response, whereas negative values represent facilitation of the reflex. The same equation was used to calculate the effects of blockade of GABA A or GABAB receptors alone on reflex responses.
Data were analyzed using the statistical package SYSTAT (version 11, SYSTAT Software, Richmond, CA). Two-way ANOVA for Values are means Ϯ SE; n, number of rats/group. *P Ͻ 0.05 vs. zero. There were no differences between responses to bicuculline versus SCH-50911. There were no differences between regional sympathetic nerve responses to both drugs. 
RESULTS
Average baseline MAP and HR values measured before the control CCR stimulus-response curves (n ϭ 51) were as follows: 84.8 Ϯ 1.4 mmHg and 398.9 Ϯ 7.2 beats/min, respectively. Baseline values measured just before NTS microinjections of drugs into the NTS returned to control levels: 82.6 Ϯ 1.5 mmHg and 398.2 Ϯ 4.6 beats/min for MAP and HR, respectively (P Ͼ 0.05). In addition, baseline MAP and HR values measured ϳ60 min after the microinjections (recovery, n ϭ 51) were not significantly different (P Ͼ 0.05) from those measured before the microinjections (79.4 Ϯ 1.5 mmHg and 379.1 Ϯ 7.4 beats/min, respectively), although MAP was slightly lower than that measured at the beginning of experiments (P ϭ 0.009). Baseline nerve activity was unaltered over time of the experiments (P Ͼ 0.05) except for a slight decrease in RSNA (P ϭ 0.018), which was comparable with the amplitude of short-term fluctuation in integrated neural activity; percent changes between the beginning of the experiment and recovery were as follows: Ϫ8.4 Ϯ 3.5%, 5.4 Ϯ 2.8%, and Ϫ2.1 Ϯ 2.8% for RSNA, ASNA, and LSNA, respectively. gradual activation of cardiopulmonary receptors by increasing doses of PBG (1-8 g/kg) evoked dose-dependent decreases in MAP and HR and uniform yet differential inhibition in regional sympathetic nerve activity (RSNA Ͼ ASNA Ͼ LSNA), similarly to previous observations (20) . Two-way ANOVA for all control data and all levels of the reflex activation showed a significant nerve effect (P Ͻ 0.0001) and nerve versus dose interaction (P ϭ 0.001). Bilateral activation of NTS adenosine A 2a receptors after pretreatment with volume control powerfully inhibited CCR hemodynamic and neural reflex responses (Figs. 3, middle, and 4, left) . This inhibition was similar to that previously observed when NTS adenosine A 2a receptors were activated without pretreatment with ACF (32). Blockade of NTS GABA A receptors virtually abolished the inhibitory effect of adenosine A 2a receptor stimulation on the CCR (Figs. 3, right, and 4, middle) . No significant differences between control versus experimental curves were found except for HR at maximal activation of the reflex and RSNA at moderate activation of the reflex (2 and 4 g PBG). Nevertheless, reflex responses of RSNA after blockade were severalfold smaller than those observed after pretreatment with ACF (compare Fig. 3 , middle vs. left). Finally, two-way ANOVA showed no significant differences (P Ͼ 0.05) between overall experimental conditions (control vs. GABA A blockade) for all variables. Differences between control and experimental reflex function curves were smaller after GABA B receptor blockade (Fig.  4 , right) compared with the effect of volume control (Fig. 4,  left) . However, some of the A 2a receptor-mediated inhibition of reflex responses persisted after GABA B blockade; two-way ANOVA showed significant experimental condition effects (P Ͻ 0.05) for all variables except for HR (Fig. 4, right) . Figure 5 shows the extent of A 2a -mediated inhibition of CCR reflex responses under each experimental condition (pretreatment with volume control vs. GABA A or GABA B receptor blockade); 100% inhibition corresponds to a completely abolished reflex response, whereas 0% change represents no inhibition of the reflex reactivity. Selective activation of A 2a receptors after volume control (ACF) markedly inhibited CCR responses. This inhibition was virtually abolished by NTS GABA A blockade; the remaining inhibition was not different from zero for HR and all neural responses except for RSNA at 4 g PBG. In contrast, after GABA B receptor blockade, the inhibition of reflex responses tended to decrease, but A 2a receptor activation still caused a significant attenuation of CCR responses. Two-way ANOVA showed a significant ACF versus GABA A blockade effect (P Ͻ 0.05 for all levels of activation of the reflex) without significant nerve effects and experimental condition versus nerve interactions. This showed that after GABA A blockade, all nerve responses to PBG were similarly restored toward control levels. GABA B blockade had a much smaller effect. Two-way ANOVA showed a significant ACF versus GABA B blockade effect only for moderate activation of the reflex [PBG (2 and 4 g/kg)].
Effects of GABAergic blockade on NTS adenosine
The reflex reactivity returned to normal levels ϳ60 min after GABA receptor blockade. No significant differences between experimental conditions were found for neural and hemodynamic variables (Table 3) . Figure 6 shows the effects of NTS GABAergic blockade alone on CCR responses. Blockade of GABA A receptors in the NTS tended to exaggerate the reflex responses (Fig. 6, left) . However, differences between control and experimental reflex function curves did not reach statistical significance (two-way ANOVA experimental effect for MAP, HR, ASNA, RSNA, and LSNA: P ϭ 0.312, 0.476, 0.128, 0.09, and 0.154, respectively). Nevertheless, when more specific comparisons of changes in reflex reactivity were measured at each level of activation of the reflex, they revealed facilitation of the reflex (Fig. 7) . Figure 7 shows percent changes of reflex responses obtained after GABA A and GABA B blockade compared with Values are means Ϯ SE; n, number of rats/group. PBG, phenylbiguanide. *P Ͻ 0.05 vs. control. There were no significant differences between control versus recovery for all variables except for the three casess at lower doses of PBG in the SCH-50911 ϩ CGS-21680 group. the respective control responses. Data were computed similarly as described in Fig. 5 ; upward deflections represent inhibition and downward deflections represent facilitation of the reflex responses. Blockade of GABA A receptors significantly facilitated CCR reflex responses of all neural and hemodynamic variables at moderate levels of CCR activation [PBG (2 and 4 g/kg)]. In contrast, GABA B receptor blockade did not alter reflex reactivity (virtually no significant differences vs. zero were found).
DISCUSSION
The present study revealed the mechanism by which adenosine, operating via A 2a receptors, exerts powerful inhibition of the CCR. When adenosine levels in the NTS rise, the activation of adenosine A 2a receptors on GABAergic neurons/terminals increases the release of GABA. This GABAergic inhibition is mediated mostly via GABA A receptors, with a much smaller contribution of GABA B receptors. The inhibition of reflex responses was similar for different regional sympathetic outputs despite the marked regional differences in response to stimulation of NTS adenosine A 2a receptors themselves as well as responses to the CCR.
Adenosine A 2a receptor-mediated GABAergic inhibition of the CCR. Adenosine, operating in the NTS via A 2a receptors, inhibits CCR responses mostly via postsynaptic GABA A receptors, with a much smaller contribution of GABA B receptors, which are located on both post-and presynaptic sites in the NTS circuitry (22, 62, 75, 76) . A 2a receptors are located mostly presynaptic in the NTS (11) . Therefore, their activation most likely facilitates GABA release from synaptic terminals. However, it does not exclude the possibility that A 2a receptors may also activate NTS GABAergic neurons via a postsynaptic mechanism. Both these mechanisms may facilitate GABA signaling, which then acts mostly via postsynaptic GABA A receptors, with much lesser effect on presynaptic action of GABA B receptors.
Consistent with the above observations, adenosine A 2a receptor-mediated facilitation of GABA release has been shown in the cerebral cortex, basal ganglia, and hippocampus (2, 13, 16, 17, 19, 28, 29, 39, 57, 72) . Furthermore, adenosine A 2a receptor-mediated facilitation of GABA release in medullary respiratory centers has been reported as injections of the A 2a receptor agonist CGS-21680 into the fourth ventricle of piglets and rats inhibited the respiratory drive, and this effect was abolished by bicuculline (28, 72) . In addition, apnea evoked by stimulation of the superior laryngeal nerve in piglets was facilitated by adenosine A 2a receptor stimulation, and this inhibition was removed by bicuculline (2) . Taken together, these data indicate that central A 2a receptors elicit both direct activation of central neurons/terminals and indirect inhibition via GABAergic mechanisms. The balance between these two reciprocal actions of A 2a receptors may differentially affect reflex integration in different NTS networks.
It should be stressed that in the NTS, adenosine operates mostly via A 2a receptors, with a much smaller contribution of A 1 receptors. For example, microinjections of adenosine and the selective A 2a receptor agonist CGS-21680 into the NTS evoke similar responses, i.e., decreases in MAP, whereas stimulation of NTS A 1 receptors evokes the opposite effect to those evoked by adenosine and the A 2a receptor agonist (5, 7) . This remains in contrast to the action of adenosine in most of the central nervous system, where A 1 receptor inhibitory action prevails (10, 43) . In the NTS, the less potent A 1 receptors inhibit both arterial baroreflex and CCR mechanisms in the NTS via direct inhibition of glutamatergic transmission in both pathways (20, 48, 53) . In contrast, the dominant adenosine A 2a receptors do not inhibit the arterial baroreflex (21); however, they selectively inhibit CCR reactivity via facilitation of GABA signaling, which, in turn, inhibits transmission in this reflex arc.
The A 2a receptor-mediated GABAergic inhibition of CCR reactivity was similar across the regional sympathetic outputs despite both the differential regional sympathetic responses to CCR activation (RSNA Ͼ ASNA Ͼ LSNA) (20, 32) as well as the reciprocal changes in basal levels of regional sympathetic activity evoked by activation of NTS adenosine A 2a receptors (50, 51) . Therefore, the triggering of GABAergic negative feedback by NTS A 2a receptors occurs via mechanisms independent of those responsible for the contrasting baseline shifts in regional sympathetic activity. The inhibitory mechanisms also seem independent from those producing differential inhibition of regional sympathetic outputs by the CCR. GABA A but not GABA B receptor blockade alone tended to disinhibit CCR responses in MAP and regional sympathetic activity (Fig. 6) . Comparison of the relative reflex reactivity before and after GABA receptor blockade (Fig. 7) suggested that endogenous GABA, operating mostly via GABA A receptors, may provide some tonic inhibition of the CCR pathway at the level of the NTS. Consistent with this observation are previous reports showing that activation of GABA A receptors inhibits responses of NTS neurons activated from the aortic depressor or vagus nerves to a greater extent than activation of GABA B receptors (71, 75) . Taken together, these data strongly suggest that tonic GABAergic inhibition of the CCR may be present at the level of the NTS. This possibility seems likely as negative GABAergic feedback operates in NTS mechanisms integrating other cardiovascular reflexes, such as the arterial baroreflex and chemoreflex networks (22, 62, 70, 75, 76) . Future, more detailed studies are needed to prove or disprove that negative GABAergic feedback operates also in the NTS CCR network.
Other potential inhibitory mechanisms that may be triggered by NTS A 2a receptors. The present study confirmed our hypothesis that NTS adenosine A 2a receptors inhibit CCR reactivity via a GABAergic mechanism with a dominant role of GABA A compared with GABA B receptors. These conclusions are based on the effects of GABA antagonists as we did not directly measure GABA levels in the NTS. Nevertheless, the inhibition was most likely mediated via direct facilitation of GABA release from nerve terminals or activation of NTS GABAergic neurons by A 2a presynaptic and postsynaptic receptors, respectively. However, indirect facilitation of GABA release by NTS adenosine A 2a receptors should be also considered. For example, activation of A 2a receptors may disinhibit GABA release via direct A 2a -D 2 interactions or via facilitation of release of vasoactive intestinal peptide, as has been shown in basal ganglia and hippocampal nerve terminals, respectively (14, 16, 19) .
Adenosine A 2a receptors may also facilitate dopamine release, and dopamine, in turn, may inhibit afferent activation of NTS neurons (24, 25, 56) . It is also possible that A 2a receptormediated facilitation of glycine release may contribute to the inhibition of the CCR (3, 18, 26) . However, this concept is less likely, because glycinergic NTS neurons were found in the lateral portions of the NTS, which are areas not involved in the integration of the CCR (8) . In addition, inhibitory potentials triggered in NTS neurons via afferent vagal stimulation were reduced by blockade of GABA but not glycine (71) .
It should be stressed that A 2a receptor-mediated inhibition of the CCR was virtually abolished by blockade of GABA A receptors and significantly attenuated by blockade of GABA B receptors (Figs. 4 and 5) . These data strongly suggest that the Limitations of the method. The limitations concerning the method of evoking the CCR responses and whole nerve recordings have been discussed in detail in our previous study (20) . Here, we focus on the limitations of blockade of GABA receptor subtypes in the NTS.
Blockade of GABAA receptors removed most of the inhibitory action of NTS A 2a receptors on CCR responses. Since blockade of GABA A receptors alone tended to facilitate CCR responses, this facilitation might have partially contributed to the removal of the inhibitory effects mediated via A 2a receptors as the direct facilitation and removal of inhibition acted in the same direction. However, this direct facilitation of the CCR response did not reach statistical significance (Fig. 6, left) , whereas the blockade virtually abolished the inhibitory effects of A 2a receptors (Figs. 4 , compare left vs. middle, and 5, residual A 2a -mediated inhibition of reflex responses after GABA A blockade was not different from zero). Therefore, the majority of A 2a receptor-mediated inhibition of the CCR occurred via activation of NTS GABAergic mechanisms.
Usually blockade of GABA A receptors in medullary nuclei is achieved with up to 500 pmol/100 nl bicuculline (33, 36, 41) . However, this level of complete blockade of GABA A receptors in the NTS was not possible as removal of negative feedback control of all autonomic reflexes integrated in the NTS results in great instability of hemodynamic and sympathetic variables, as observed during preliminary studies. Figure 8 shows the effect of bilateral microinjection of 100 pmol bicuculline in 100 nl ACF on baseline levels of hemodynamic variables and regional sympathetic nerve activity. High-amplitude flickering of baseline values occurred in all variables. Therefore, in preliminary studies, we assessed the optimal dose of the antagonist that would effectively inhibit NTS GABAergic mechanisms but not destabilize the resting baseline values so that reflex responses could be analyzed and compared with control conditions. We achieved this effect with microinjections of 10 pmol bicuculline in a 100-nl volume. Microinjections of 100 nl into the NTS are required to fully inhibit NTS mechanisms. For example, 100 nl kynurenic acid microinjected into the NTS is needed to effectively block arterial baroreflex responses, whereas smaller volumes of the drug do not block the responses completely (63) . We used this volume of antagonists in several previous studies (20, 21, 31, 48, 52, 53, 55) . One may speculate that the instability of baseline levels shown in Fig. 8 may be a result of penetration of bicuculline to cardiovascular centers in the ventrolateral medulla. However, this seems unlikely, as concentration of the drug decreases with third power of the radius around the microinjection site; therefore, even if bicuculline could penetrate into the ventrolateral medulla, the concentration would be over 100-fold lower than that in the NTS. It should be stressed that effective blockade of GABA A receptors in the rostral ventrolateral medulla was achieved with doses up to 500 pmol/100 nl (33, 36, 41) . Finally, we have previously shown that microinjections of A 2a receptor agonist (CGS-21680) inadvertently performed on the border of the NTS or just outside the NTS evoked delayed and markedly decreased cardiovascular responses compared with the effects of microinjections made inside the NTS (50) . In the present study, blockade of GABAA and GABAB receptors located in the NTS was performed in sinoaortic denervated animals. Therefore, we observed much smaller decreases in MAP, HR, and regional sympathetic activity after blockade than those observed previously in sinoaortic intact animals, where most of the decreases are mediated via disinhibition of arterial baroreflex mechanisms (22, 35, 62, 68) .
Perspectives
The present study revealed the presence of GABAergic inhibition of the CCR, which may be triggered by stimulation of NTS adenosine A 2a receptors. NTS adenosine A 1 receptors exert similarly powerful inhibition of the CCR (20) . Although adenosine A 1 receptors inhibit also arterial baroreflex pathway at the level of the NTS, A 2a receptors selectively inhibit the CCR but not arterial baroreflex pathway (21, 48) . Taken together, these data show that adenosine operating in the NTS powerfully inhibits CCR mechanisms via synergistic action of both antagonistic receptor subtypes (dominant A 2a and secondary A 1 receptors), whereas the arterial baroreflex is inhibited to much lesser extent, as this occurs only via adenosine A 1 receptors. Why, then, does adenosine exert such powerful inhibition of the CCR pathway compared with the much smaller inhibition of the arterial baroreflex pathway? It is likely that this powerful modulation of the CCR via both adenosine receptor subtypes has physiological implications. The CCR (also known as the Bezold-Jarisch reflex) evokes life-threatening decreases in MAP via marked sympathoinhibition, peripheral vasodilation, and severe bradycardia, which may result in fainting (9, 27, 44) . This reflex has even been implicated in mediating sudden cardiac death in young athletes (9) . The powerful reflex decreases in MAP may lead to brain stem hypoxia and the release of adenosine. Therefore, adenosine may work as a negative feedback regulator of this particular sympathoinhibitory reflex, as shown in Fig. 9 . During cardiac ischemia, moderate activation of the CCR, buffered by simultaneous activation of sympathetic afferents, may be helpful, as it would reduce afterload and decrease O 2 demand in the hypoxic heart. However, powerful activation of this reflex may be detrimental, as amplification of the hypotension might lead to death. During this severe hypotension, adenosine may be released into the NTS and powerfully inhibit the CCR via both receptor subtypes operating via very distinct mechanisms: direct inhibition of glutamatergic neurotransmission in the CCR pathway (A 1 receptors) and facilitation of GABA release (A 2a receptors). This synergistic inhibitory action of both adenosine receptor subtypes may act as a strong negative feedback regulator for the CCR, preventing the life-threatening effects of powerful activation of this reflex. This hypothetical role of adenosine in the feedback control of CCR reactivity needs further investigation, which may directly show that during powerful and long-lasting activation of the CCR, adenosine levels in the NTS increase as they do during hypotension in the course of severe hemorrhage (31, 55, 69) .
